BRIBF
Price
$0.24
Change
+$0.01 (+4.35%)
Updated
Aug 1 closing price
Capitalization
180.48M
IMMX
Price
$2.38
Change
-$0.22 (-8.46%)
Updated
Aug 7, 04:57 PM (EDT)
Capitalization
66.63M
27 days until earnings call
Interact to see
Advertisement

BRIBF vs IMMX

Header iconBRIBF vs IMMX Comparison
Open Charts BRIBF vs IMMXBanner chart's image
BRII BIOSCIENCE
Price$0.24
Change+$0.01 (+4.35%)
Volume$2.38K
Capitalization180.48M
Immix Biopharma
Price$2.38
Change-$0.22 (-8.46%)
Volume$100
Capitalization66.63M
BRIBF vs IMMX Comparison Chart in %
Loading...
BRIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRIBF vs. IMMX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRIBF is a Hold and IMMX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BRIBF: $0.24 vs. IMMX: $2.60)
Brand notoriety: BRIBF and IMMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRIBF: 22% vs. IMMX: 215%
Market capitalization -- BRIBF: $180.48M vs. IMMX: $66.63M
BRIBF [@Biotechnology] is valued at $180.48M. IMMX’s [@Biotechnology] market capitalization is $66.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRIBF’s FA Score shows that 0 FA rating(s) are green whileIMMX’s FA Score has 0 green FA rating(s).

  • BRIBF’s FA Score: 0 green, 5 red.
  • IMMX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMMX is a better buy in the long-term than BRIBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRIBF’s TA Score shows that 2 TA indicator(s) are bullish while IMMX’s TA Score has 4 bullish TA indicator(s).

  • BRIBF’s TA Score: 2 bullish, 4 bearish.
  • IMMX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMMX is a better buy in the short-term than BRIBF.

Price Growth

BRIBF (@Biotechnology) experienced а -2.16% price change this week, while IMMX (@Biotechnology) price change was -5.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Reported Earning Dates

IMMX is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRIBF($180M) has a higher market cap than IMMX($66.6M). BRIBF YTD gains are higher at: 91.790 vs. IMMX (17.955).
BRIBFIMMXBRIBF / IMMX
Capitalization180M66.6M270%
EBITDAN/A-21.62M-
Gain YTD91.79017.955511%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A15.9M-
Total DebtN/A1.06M-
TECHNICAL ANALYSIS
Technical Analysis
BRIBFIMMX
RSI
ODDS (%)
Bullish Trend 2 days ago
25%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
23%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BRIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYKOF17.13N/A
N/A
Kyowa Hakko Kogyo Co., Ltd.
VULMF0.07N/A
N/A
Vulcan Minerals Inc.
KBAGF5.45N/A
N/A
Koninklijke BAM Groep NV
TTGPF1.25N/A
N/A
TT Electronics PLC
AWSL0.04N/A
-6.51%
Atlantic Power & Infrastructure Corp.

BRIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRIBF has been loosely correlated with HLVX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BRIBF jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRIBF
1D Price
Change %
BRIBF100%
N/A
HLVX - BRIBF
55%
Loosely correlated
N/A
NRSN - BRIBF
6%
Poorly correlated
-2.90%
VIGL - BRIBF
6%
Poorly correlated
N/A
IMMX - BRIBF
6%
Poorly correlated
-8.95%
GNTA - BRIBF
5%
Poorly correlated
+0.53%
More

IMMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMX has been loosely correlated with IMTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMX jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-8.95%
IMTX - IMMX
36%
Loosely correlated
-4.66%
XERS - IMMX
35%
Loosely correlated
+0.18%
CRNX - IMMX
34%
Loosely correlated
-2.43%
COGT - IMMX
33%
Loosely correlated
-3.43%
SYRE - IMMX
31%
Poorly correlated
-5.39%
More